BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 10328749)

  • 1. Activation of microsomal glutathione S-transferase and inhibition of cytochrome P450 1A1 activity as a model system for detecting protein alkylation by thiourea-containing compounds in rat liver microsomes.
    Onderwater RC; Commandeur JN; Menge WM; Vermeulen NP
    Chem Res Toxicol; 1999 May; 12(5):396-402. PubMed ID: 10328749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin.
    Chun YJ; Ryu SY; Jeong TC; Kim MY
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):389-93. PubMed ID: 11259321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cytotoxicity of N-substituted N'-(4-imidazole-ethyl)thiourea in precision-cut rat liver slices.
    Onderwater RC; Commandeur JN; Vermeulen NP
    Toxicology; 2004 Apr; 197(2):81-91. PubMed ID: 15003319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism-based inactivation of cytochrome P450 1A1 by N-aralkyl-1-aminobenzotriazoles in guinea pig kidney in vivo and in vitro: minimal effects on metabolism of arachidonic acid by renal P450-dependent monooxygenases.
    Knickle LC; Webb CD; House AA; Bend JR
    J Pharmacol Exp Ther; 1993 Nov; 267(2):758-64. PubMed ID: 8246152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases.
    Weber GF; Waxman DJ
    Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triphenyltin acetate-mediated in vitro inactivation of rat liver cytochrome P-450.
    Nebbia C; Ceppa L; Dacasto M; Carletti M
    J Toxicol Environ Health A; 1999 Mar; 56(6):433-47. PubMed ID: 10096365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
    Ferrara R; Tolando R; King LJ; Manno M
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism-based inactivation of hepatic ethoxyresorufin O-dealkylation activity by naturally occurring coumarins.
    Cai Y; Baer-Dubowska W; Ashwood-Smith MJ; Ceska O; Tachibana S; DiGiovanni J
    Chem Res Toxicol; 1996 Jun; 9(4):729-36. PubMed ID: 8831817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfoxidation of mercapturic acids derived from tri- and tetrachloroethene by cytochromes P450 3A: a bioactivation reaction in addition to deacetylation and cysteine conjugate beta-lyase mediated cleavage.
    Werner M; Birner G; Dekant W
    Chem Res Toxicol; 1996; 9(1):41-9. PubMed ID: 8924615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver microsome and flavin-containing monooxygenase catalyzed oxidation of organic selenium compounds.
    Chen GP; Ziegler DM
    Arch Biochem Biophys; 1994 Aug; 312(2):566-72. PubMed ID: 8037472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics and selectivity of mechanism-based inhibition of guinea pig hepatic and pulmonary cytochrome P450 by N-benzyl-1-aminobenzotriazole and N-alpha-methylbenzyl-1-aminobenzotriazole.
    Sinal CJ; Bend JR
    Drug Metab Dispos; 1996 Sep; 24(9):996-1001. PubMed ID: 8886610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH-dependent, regioselective S-oxidation of a thionosulfur- and thioether-containing xenobiotic, diethyldithiocarbamate methyl ester by rat liver microsomes.
    Madan A; Faiman MD
    Drug Metab Dispos; 1994; 22(2):324-30. PubMed ID: 8013289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in tamoxifen activation.
    Mani C; Kupfer D
    Cancer Res; 1991 Nov; 51(22):6052-8. PubMed ID: 1933868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
    Chun YJ; Kim MY; Guengerich FP
    Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms.
    Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of dipropyl disulfide by rat liver phase I and phase II enzymes and by isolated perfused rat liver.
    Teyssier C; Siess MH
    Drug Metab Dispos; 2000 Jun; 28(6):648-54. PubMed ID: 10820136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro biotransformation of 3,4-dihydro-6-hydroxy-2,2-dimethyl-7-methoxy-1(2H)-benzopyran (CR-6), a potent lipid peroxidation inhibitor and nitric oxide scavenger, in rat liver microsomes.
    Yenes S; Commandeur JN; Vermeulen NP; Messeguer A
    Chem Res Toxicol; 2004 Jul; 17(7):904-13. PubMed ID: 15257615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH dependent activation of microsomal glutathione transferase 1.
    Rinaldi R; Aniya Y; Svensson R; Eliasson E; Swedmark S; Shimoji M; Morgenstern R
    Chem Biol Interact; 2004 Mar; 147(2):163-72. PubMed ID: 15013818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
    Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
    Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.